Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

For decades, scientists assumed that neural stem cells (NSCs) only occur in the brain and spinal cord. A new international ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

These organoids provide scientists with better models for studying liver biology, and for developing treatments for various liver disorders.

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

In the short term, these multi-zonal liver organoids will help scientists shed new light on diseases including diabetes, drug-induced liver injury, alcohol-related liver disease, and viral hepatitis.

One reason why our livers excel at clearing waste from our blood system is that the organ functions according to three key ...

As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations.

“Metabolism ... stem cells; it does the same in cancer cells, Finley’s team and other groups found a few years ago. They were studying p53, a protein that is well known for its anticancer effects; its ...